Merck KGaA Articles
Merck receives FDA warning over plant safety
5 May 2008
Merck & Co shares fall 5.1% after
5 May 2008
No to Merck & Co/S-P combo allergy drug
5 May 2008
GSK in cliffhanger on vacc reimbursement
5 May 2008
S-P profit down, sales up on Organon buy
5 May 2008
US drugmakers switch marketing approach
5 May 2008
Merck & Co 1Q results saved by AZ payout
28 April 2008
Pertussis vacc for all adults in France
28 April 2008
Stock Commentary - Europe - week to April 21, 2008
28 April 2008
Express Scripts' US health cost initiative
28 April 2008
SkyePharma secures Flutiform Japan partner
28 April 2008
Merck KGaA/WHO start Africa schistosomiasis program
28 April 2008
FDA gives update on HEPLISAV clinical hold
28 April 2008
Merck appoints new board member
21 April 2008
Stock Commentary - Europe - week to April 14, 2008
21 April 2008
Merck to invest $50M in US Research Centre
21 April 2008
Retail drug sales in year to January 2008
21 April 2008
Richard Clark elected chairman of PhRMA board
14 April 2008
Stock Commentary - New York week to April 7, 2008
14 April 2008
BioXell's FY 2007 net loss flat at $21.4M
14 April 2008
Merck & Co to study Iomai vacc booster patch
14 April 2008
Class action against Merck & Co
14 April 2008
TG licenses Sirna's HD RNAi program
14 April 2008
Stock Commentary - New York week to March 31, 2008
7 April 2008
Crestor sales hopes raised by JUPITER trial
7 April 2008
Evotec's 2007 net loss narrows to 11.2M euros
7 April 2008
Taranabant: double the weight loss of placebo
7 April 2008
Late-stage Cordaptive trial stalls on IMT issue
7 April 2008
Zetia "could be expensive placebo," ACC hears
7 April 2008
Mylan seeks more generic market share
7 April 2008
FDA investigates suicide link with Singulair
7 April 2008
Clinical hold on Heplisav by FDA
31 March 2008
Merck & Co's Gardasil gets priority US review
31 March 2008
Market slowdown for dyslipidemia drugs
31 March 2008
Thailand's GPO: CVD and ARV copycats plan
31 March 2008
US MDs do not Rx to HLD guidelines
31 March 2008
Belgium's drugmakers welcome 26 new drugs
31 March 2008
Merck Serono's Cyanokit debuts in Japan
24 March 2008
South Africa approves HPV vaccines
24 March 2008
Potential anti-obesity gene targets in mice
24 March 2008
Mylan plans big push into Japanese generics market
24 March 2008
Merck KGaA plans further acquisitions
17 March 2008
GSK HPV vacc provides longest protection
17 March 2008
Merck & Co and Marcadia accord
17 March 2008
Acquired R&D cost impairs Mylan's 4th qtr
17 March 2008
Stock Commentary - New York week to March 3, 2008
10 March 2008
Danish gov approves free HPV vaccination
10 March 2008
NicOx' FY 2007 income doubles, big year ahead
10 March 2008
Merck & Co sells JV products to AZ
10 March 2008
Merck & Co reports on Vioxx law suits
10 March 2008
New Rebif formulation launched in UK
10 March 2008
Stock Commentary - Europe - week to Feb 25, 2008
3 March 2008
Japan stock market week to Feb 25, 2008
3 March 2008
Small generic firms struggle in France
3 March 2008
Newron says EPO will issue safinamide patent for PD
3 March 2008
US Pres promises $350M for neglected diseases
3 March 2008
Teva says Dutch part of MSD's Fosamax patent revoked
3 March 2008
US Pres promises $350M for neglected diseases
3 March 2008
UPDATE: GPhA sees US prospects in 2008, Rx share at 65%
25 February 2008
Stock Commentary - New York week to Feb 18, 2008
25 February 2008
Doctors claim statins cause memory loss
25 February 2008
Generic Rxing hits 65% of US market
25 February 2008
Sanofi Pasteur MSD submits ID flu vacc to EMEA
18 February 2008
Stock Commentary - New York week to Feb 11, 2008
18 February 2008
Stock Commentary - Europe - week to Feb 11, 2008
18 February 2008
US congressional committee widens Vytorin investigation
18 February 2008
S-P's 4th-qtr 2007 results hit by Organon buy
18 February 2008
Karo Bio's 2007 loss up 63% on R&D costs
18 February 2008
UK's NICE asked to develop new clinical health guidance for DoH
18 February 2008
Isentress: significant HIV load suppression up to 48 weeks
18 February 2008
Merck & Co's $671M rebate settlement
18 February 2008
ImClone's 4th-qtr hurt by $60M settlement
14 February 2008
Gardasil's efficacy confirmed in Ph II/III program with 20,000 women
11 February 2008
FDA issues "non-approvable" letter for Merck & Co
11 February 2008
Watson and Barr launch generic Fosamax in USA
11 February 2008
Stock Commentary - New York week to Feb 4, 2008
11 February 2008
Stock Commentary - Europe - week to Feb 4, 2008
11 February 2008
Glenmark and Merck KGaA end GRC8200 deal
11 February 2008
Osteoporosis a continuing challenge for GPs in the UK, says MSD
11 February 2008
IFPMA increases assistance to WHO-based TDR program
4 February 2008
- Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- Proposal to list Roche's Neulastim and Actemra in New Zealand
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
